Research Article - (2014) Volume 7, Issue 9
Validation of Biomarkers in Gene Expression Datasets of Inflammatory
Bowel Disease: IL13RA2, PTGS2 and WNT5A as Predictors of
Responsiveness to Infliximab Therapy
- András Gyorffy1, Máté Kormos1, Luca Bartha1, András Szabó2, Balázs Gyorffy2,3, Jan Budczies4 and Barna Vásárhelyi1,5*
- 1MTA-SE Pediatrics and Nephrology Research Group, Budapest, Hungary
- 22nd Department of Pediatrics, Semmelweis University, Budapest, Hungary
- 3MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary
- 4Institute of Pathology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany
- 5Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary
*Corresponding Author:
Barna Vásárhelyi, Department of Laboratory Medicine, Semmelweis University, Nagyvárad Tér 4.1089 Budapest, Hungary, Tel: 0036-20-6663246 Exn. 56492, Fax: 0036-1-2100278
